Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Managing patients with antibodies to high- frequency antigens - our experience (CROSBI ID 692842)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Raos, Mirela ; Lukic, Marija ; Plenkovic, Fini ; Golubic Cepulic, Branka Managing patients with antibodies to high- frequency antigens - our experience // Vox Sanguinis. 2017. str. 201-201

Podaci o odgovornosti

Raos, Mirela ; Lukic, Marija ; Plenkovic, Fini ; Golubic Cepulic, Branka

engleski

Managing patients with antibodies to high- frequency antigens - our experience

An investigation of the antibody to a high- frequency antigen (HFA) is both very demanding and time consuming. Although some of the antibodies that are serologically difficult to identify are those with the least clinical significance (i.e. anti-Csa, -Ch, -Rg, -Yta, -JMH), many have been responsible for immediate HTR (i.g. anti-Vel, Inb), delayed HTR (i.g. anti-Kpb, - Jsb), severe HDFN (i.g. anti-k, anti-RH17) or mild HDFN (i.g. anti-K18) where antigen negative blood should be transfused. While HFA-negative subjects are excessively rare amongst white people, transfusion management in patients with HFA alloantibodies is often difficult.

Antibodies to high-frequency antigens

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

201-201.

2017.

objavljeno

Podaci o matičnoj publikaciji

Vox Sanguinis

Podaci o skupu

27th Regional Congress of the ISBT

poster

17.06.2017-21.06.2017

Kopenhagen, Danska

Povezanost rada

nije evidentirano